Logo image
Red fluorescent zinc oxide nanoparticle: a novel platform for cancer targeting
Journal article   Peer reviewed

Red fluorescent zinc oxide nanoparticle: a novel platform for cancer targeting

Hao Hong, Fei Wang, Yin Zhang, Stephen A Graves, Savo Bou Zein Eddine, Yunan Yang, Charles P Theuer, Robert J Nickles, Xudong Wang and Weibo Cai
ACS applied materials & interfaces, Vol.7(5), pp.3373-3381
02/11/2015
DOI: 10.1021/am508440j
PMCID: PMC4326560
PMID: 25607242
url
https://www.osti.gov/servlets/purl/1345171View
Open Access

Abstract

Multifunctional zinc oxide (ZnO) nanoparticles (NPs) with well-integrated multimodality imaging capacities have generated increasing research interest in the past decade. However, limited progress has been made in developing ZnO NP-based multimodality tumor-imaging agents. Here we developed novel red fluorescent ZnO NPs and described the successful conjugation of 64Cu (t1/2=12.7 h) and TRC105, a chimeric monoclonal antibody against CD105, to these ZnO NPs via well-developed surface engineering procedures. The produced dual-modality ZnO NPs were readily applicable for positron emission tomography (PET) imaging and fluorescence imaging of the tumor vasculature. Their pharmacokinetics and tumor-targeting efficacy/specificity in mice bearing murine breast 4T1 tumor were thoroughly investigated. ZnO NPs with dual-modality imaging properties can serve as an attractive candidate for future cancer theranostics.
Animals Antibodies, Monoclonal - pharmacokinetics Breast Neoplasms - diagnostic imaging Breast Neoplasms - metabolism Breast Neoplasms - pathology Cell Line, Tumor Copper Radioisotopes - pharmacokinetics Female Fluorescent Dyes - chemistry Metal Nanoparticles - chemistry Metal Nanoparticles - ultrastructure Mice Mice, Inbred BALB C Microscopy, Fluorescence - methods Multimodal Imaging - methods Nanocapsules - chemistry Nanocapsules - ultrastructure Positron-Emission Tomography - methods Radiopharmaceuticals - pharmacokinetics Zinc Oxide

Details

Metrics

Logo image